Literature DB >> 15629130

Cloning and characterization of two endoxylanases from the cereal phytopathogen Fusarium graminearum and their inhibition profile against endoxylanase inhibitors from wheat.

Tim Beliën1, Steven Van Campenhout, Maarten Van Acker, Guido Volckaert.   

Abstract

Two genes encoding family 11 endo-beta-1,4-xylanases (XylA, XylB) from Fusarium graminearum were cloned and expressed in Escherichia coli. The amount of active endoxylanase in the cytoplasmic soluble fraction was considerably improved by varying different expression parameters, including host strain and temperature during induction. Both recombinant endoxylanases showed a temperature optimum around 35 degrees C and neutral pH optima (around pH 7 and 8 for XylB and XylA, respectively). For the first time this allowed one to test endoxylanases of a phytopathogenic organism for inhibition by proteinaceous endoxylanase inhibitors TAXI and XIP. Whereas XylA and XylB were inhibited by TAXI-I, no inhibition activity could be detected upon incubation with XIP-I. The insensitivity of both F. graminearum endoxylanases towards XIP is surprising, since the latter is typically active against endoxylanases produced by (aerobic) fungi. As F. graminearum is an important phytopathogen, these findings have implications for the role of endoxylanase inhibitors in plant defence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15629130     DOI: 10.1016/j.bbrc.2004.12.036

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  TLXI, a novel type of xylanase inhibitor from wheat (Triticum aestivum) belonging to the thaumatin family.

Authors:  Ellen Fierens; Sigrid Rombouts; Kurt Gebruers; Hans Goesaert; Kristof Brijs; Johnny Beaugrand; Guido Volckaert; Steven Van Campenhout; Paul Proost; Christophe M Courtin; Jan A Delcour
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

2.  Fusarium graminearum as a producer of xylanases with low cellulases when grown on wheat bran.

Authors:  Jhon Cruz-Davila; Jeffrey Vargas Perez; Daynet Sosa Del Castillo; Nardy Diez
Journal:  Biotechnol Rep (Amst)       Date:  2022-05-17

3.  Xyr1 regulates xylanase but not cellulase formation in the head blight fungus Fusarium graminearum.

Authors:  Kurt Brunner; Anton M Lichtenauer; Klaus Kratochwill; Marizela Delic; Robert L Mach
Journal:  Curr Genet       Date:  2007-10-09       Impact factor: 3.886

4.  Mutational analysis of endoxylanases XylA and XylB from the phytopathogen Fusarium graminearum reveals comprehensive insights into their inhibitor insensitivity.

Authors:  Tim Beliën; Steven Van Campenhout; Maarten Van Acker; Johan Robben; Christophe M Courtin; Jan A Delcour; Guido Volckaert
Journal:  Appl Environ Microbiol       Date:  2007-05-18       Impact factor: 4.792

5.  Genome-Wide Analysis in Three Fusarium Pathogens Identifies Rapidly Evolving Chromosomes and Genes Associated with Pathogenicity.

Authors:  Jana Sperschneider; Donald M Gardiner; Louise F Thatcher; Rebecca Lyons; Karam B Singh; John M Manners; Jennifer M Taylor
Journal:  Genome Biol Evol       Date:  2015-05-19       Impact factor: 3.416

6.  Molecular characterization of a new alkaline-tolerant xylanase from Humicola insolens Y1.

Authors:  Pengjun Shi; Yanlong Du; Hong Yang; Huoqing Huang; Xiu Zhang; Yaru Wang; Bin Yao
Journal:  Biomed Res Int       Date:  2015-01-05       Impact factor: 3.411

7.  Genomic characterization of plant cell wall degrading enzymes and in silico analysis of xylanases and polygalacturonases of Fusarium virguliforme.

Authors:  Hao-Xun Chang; Craig R Yendrek; Gustavo Caetano-Anolles; Glen L Hartman
Journal:  BMC Microbiol       Date:  2016-07-12       Impact factor: 3.605

8.  Characterizing a Halo-Tolerant GH10 Xylanase from Roseithermus sacchariphilus Strain RA and Its CBM-Truncated Variant.

Authors:  Seng Chong Teo; Kok Jun Liew; Mohd Shahir Shamsir; Chun Shiong Chong; Neil C Bruce; Kok-Gan Chan; Kian Mau Goh
Journal:  Int J Mol Sci       Date:  2019-05-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.